Top Markets
Coin of the day
Zhejiang Taimei Medical Technology Co., Ltd. Zhejiang Taimei Medical Technology Co., Ltd.

Zhejiang Taimei Medical Technology Co., Ltd.

2576
Rank in Stocks #15029
Zhejiang Taimei Medical Technology Co., Ltd., established in 2013 and based in... Zhejiang Taimei Medical Technology Co., Ltd., established in 2013 and based in Jiaxing, China, specializes in delivering sophisticated digital operational platforms specifically designed for the biopharmaceutical industry across the country. The company's core offering is TrialOS, a comprehensive digital collaboration platform that seamlessly integrates all participants throughout the drug development and research lifecycle. This ecosystem effectively links hospitals, pharmaceutical firms, external service providers, regulatory bodies, and patients, among other key industry stakeholders. Its extensive portfolio of software solutions caters to various critical aspects of clinical research and drug development. For streamlining clinical trial operations, Taimei Medical provides tools like eCooperate, which optimizes management systems and leverages big data for informed decision-making. Other related offerings include eArchives for managing master files, eCollect for electronic data capture, eCollege for training administration, eQuality for electronic audit processes, and eBalance for interactive web-based responses. Innovations such as eVisit Patient Reported Outcomes are designed to enhance patient data input and accuracy, while eTime supports project time management, and eImage facilitates medical image interpretation. Furthermore, the company supplies specialized software tailored for hospitals and Good Clinical Practice (GCP) sites. These include eTrial for managing Phase I wards, eSite and NomenCTMS for comprehensive clinical trial management at study sites, and intelligent platforms like GCP-X and Intelligent Investigator. Solutions such as eScreening assist with subject information management and deduplication, while IIT-EDC and the Investigator-Initiated Clinical Trial Management System support investigator-initiated studies and their associated data management. In the crucial domain of drug safety, the company offers robust pharmacovigilance software solutions. This includes both global and intelligent eSafety systems, alongside the SAE Manager for efficient communication and management of critical safety data during clinical trials. Complementing these, Zhejiang Taimei also develops marketing software and a variety of other digital innovation solutions.
Share Price
$0.67033345
Market Cap
$377.97M
Change (1 day)
-3.68%
Change (1 year)
5.38%
Country
CN
Trade Zhejiang Taimei Medical Technology Co., Ltd. (2576)

Category

Stock split history for Zhejiang Taimei Medical Technology Co., Ltd. (2576)
Zhejiang Taimei Medical Technology Co., Ltd. stock (symbol: 2576) underwent a total of 0 stock splits.
The most recent stock split occurred on Sep 01, 2026.
One 2576 share bought prior to Sep 01, 2026 would equal to 0 2576 shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
4 x600
DE
1 x4
US
0 -
CA
0 -
US
1 x4
US